Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lot-to-lot Consistency and Safety of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried in Healthy Individuals Aged 18-45 Years: A Randomized, Double-Blind Phase IIIb Clinical Trial

NCT07416110 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.

NCT NCT07416110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07416110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lot-to-lot Consistency and Safety of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried in Healthy Individuals Aged 18-45 Years: A Randomized, Double-Blind Phase IIIb Clinical Trial
Lead sponsor
Sinovac Biotech Co., Ltd
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 4, 2026
Completion date
June 30, 2027
Enrollment
912 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rabies (healthy volunteers)